Early clinical results support Da Vinci FS laser

September 11, 2006

Swiss firm, Ziemer Ophthalmic Systems took advantage of the ESCRS congress to reveal its femtosecond laser Da Vinci to the ophthalmic community.

Swiss firm, Ziemer Ophthalmic Systems took advantage of the ESCRS congress to reveal its femtosecond laser Da Vinci to the ophthalmic community.

During wet lab demonstrations, ophthalmologists took the opportunity to sample the Da Vinci systems, the first series of which are making their way off the assembly line and into more extensive clinical testing.

Following an initial series of regular clinical applications, performed in collaboration with refractive surgeons in Switzerland, Germany and the UK, LASIK flaps were created in the corneas of LASIK patients, followed by standard excimer laser ablation.

According to the surgeons, the Femto-LASIK procedure was uneventful and yielded satisfactory outcomes with target refraction achieved and no complications reported. At two-week follow-up, there were no apparent signs of laser-induced complications.

Ophthalmology Times Europe reporting from the XXIV Congress of the ESCRS, London, 9-13 September, 2006.